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Abstract	  
 Polyhydroxyalkanoates	  (PHAs)	  are	  a	  common	  family	  of	  biodegradable	  plastics	  that	  
are	  used	  to	  create	  a	  variety	  of	  bulk-­‐commodity	  plastics.	  Polyhydroxybutyrate	  (PHB)	  
belongs	  to	  the	  PHA	  family	  of	  bioplastics	  and	  has	  been	  the	  most	  widely	  studied	  PHA	  
member.	  As	  presence	  of	  biodegradable	  plastics,	  such	  as	  PHB,	  become	  more	  prevalent	  in	  
everyday	  products,	  it	  is	  of	  increasing	  interest	  to	  understand	  how	  these	  plastics	  are	  being	  
degraded	  in	  the	  natural	  environment.	  Pseudomonas	  aeruginosa	  is	  a	  common	  soil	  bacterium	  
that	  exhibits	  the	  ability	  to	  degrade	  PHB	  and	  use	  the	  monomer	  of	  this	  polymer,	  D-­‐3-­‐
hydroxybutyrate	  (D-­‐3-­‐HB),	  as	  a	  carbon	  source.	  P.	  aeruginosa	  converts	  D-­‐3-­‐HB	  into	  
acetoacetate	  through	  the	  enzymatic	  action	  of	  the	  cytosolic	  protein	  D-­‐3-­‐hydroxybutyrate	  
dehydrogenase	  (BdhA).	  Directly	  adjacent	  to	  the	  bdhA	  gene	  within	  the	  P.	  aeruginosa	  genome	  
are	  the	  PA2004	  and	  PA2005	  genes,	  the	  three	  of	  which	  are	  all	  believed	  to	  be	  the	  primary	  
genes	  involved	  in	  D-­‐3-­‐HB	  metabolism.	  Using	  mutant	  strains	  of	  P.	  aeruginosa	  lacking	  the	  
function	  of	  the	  bdhA,	  PA2004,	  or	  PA2005	  genes,	  complementation	  assays	  were	  performed	  
to	  determine	  the	  role	  of	  these	  genes	  in	  D-­‐3-­‐HB	  metabolism.	  The	  experimental	  results	  
proved	  that	  the	  PA2004	  gene	  codes	  for	  a	  putative	  transporter	  protein	  responsible	  for	  the	  
uptake	  of	  D-­‐3-­‐HB	  into	  the	  cell	  and	  the	  PA2005	  gene	  encodes	  an	  enhancer	  binding	  protein	  
that	  mediates	  expression	  of	  the	  bdhA-­‐PA2004	  gene	  operon.	  Characterization	  of	  PA2005	  
gene	  function,	  as	  well	  as	  the	  putative	  transporter	  of	  D-­‐3-­‐HB,	  encoded	  by	  the	  PA2004	  gene,	  
has	  provided	  insight	  into	  the	  genetic	  and	  metabolic	  processes	  responsible	  for	  PHB	  
degradation	  by	  P.	  aeruginosa.	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Introduction	  
 A trademark of life in the 21st century is the presence of plastic materials. Items ranging 
from automobiles parts to surgically implanted hips all utilize plastic based products. The most 
commonly used chemical synthesis methods for the production of many plastics require 
petroleum precursors. Additionally, petroleum-based plastics take years to degrade and have 
adverse effects on the environment.  
Recently, there has been mounting interest in the development of biodegradable plastics, 
especially in regards to current dependence on petroleum based energy sources for the 
production of the majority of plastics being used today [3]. Additionally, most traditional plastics 
have adverse affects on the environment due to their inability to decompose, which causes 
buildup in landfills, harm to a variety of animals that become entangled is disposed plastic 
material, and potential environmental toxicity caused by leaching [10]. Biodegradable plastics 
provide a sustainable remedy to these issues through the use of microorganisms to create the 
desired material as well as the ability of microorganisms to degrade these plastics once they are 
returned to the environment [4].  
Polyhydroxyalkanoates or PHA is a common family of bioplastics that are synthesized by 
bacteria and have been used to create bulk-commodity plastics, as well as products such as 
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biofuels, drug delivery carriers, and medical implants [2]. Polyhydroxybutyrate (PHB) belongs to 
the PHA family (Figure 1) of bioplastics and was first discovered in 1926 by French scientist 
Maurice Lemoigne [3]. Since its discovery, PHB has been the most widely studied PHA member 
and considerable progress has been made in developing new production methods to improve the 
applicability of this material [2]. Optimization of PHB production has also lead to techniques 
that all for a variety of microorganisms to produce this material, some in levels of up to 90% cell 
dry weight [12]. As the demand for using microorganisms to produce bioplastics as an 
alternative to traditional plastic materials increases, understanding the pathways for natural PHB 
degradation is of increasing significance.  
 
Figure 1; Structure of PHA backbone and R-group present in PHB 
The variety of bioplastics being used in industrial applications have been chosen based on 
factors such as biocompatibility, flexible strength, thermal resistance, and biodegradability [2]. 
Every bioplastic is unique in molecular structure, so if degradation is to be accomplished by 
microorganisms, specific enzymatic mechanisms are required [10]. Therefore, the potential for 
degradation of a specific bioplastic is dependent on the variety of microorganisms present in the 
environment.  
Pseudomonas aeruginosa is a gram-negative soil bacterium found ubiquitously 
throughout nature [6]. This opportunistic pathogen displays a highly versatile metabolism and 
has been known to cause extremely virulent nosocomial infections, burn wound infections, lung 
infections in individuals with cystic fibrosis, and urinary tract infections [6].  In addition to its 
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pathogenic role, Pseudomonas aeruginosa is also associated with the production of various 
biodegradable plastics, such as polyhydroxyalkanoates (PHA) [5]. Despite the relatively 
common appearance of PHB producing bacteria, P. aeruginosa does not appear to produce this 
form of PHA [5]. Coincidentally, P. aeruginosa strains appear to have the ability to degrade 
PHB use the monomer of this polymer, D-3-hydroxybutyrate (D-3-HB) (Figure 2), as a carbon 
source, likely as a method for sequestering nutrients from competing organisms in the 
environment that do produce PHB [5,7].  
 
Figure 2; Structure D-3-Hydroxybutyrate 
The degradation of poly-3-hydroxybutyrate (PHB) in Pseudomonas aeruginosa likely 
begins with the excretion of an extracellular depolymerase coded by the PhaZ gene, as 
demonstrated in other Pseudomonas species [13]. This esterase is likely similar to that of P. 
stutzeri and may have broad digestion abilities beyond PHB alone [13].  Although it is not yet 
understood how the P. aeruginosa cell is able to uptake D-3-HB, utilization of this short chain 
carboxylic acid as a source of energy has been documented [7]. The cytosolic enzyme, D-3-
hydroxybutyrate dehydrogenase (BdhA), along with NAD+ as a co-substrate catalyzes the 
conversion of D-3-hydroxybutyrate to acetoacetate (Figure 3) [7]. Once converted to 
acetoacetate, this substrate can be subsequently converted to acetoacetyl-CoA, and then to 
acetyl-CoA, followed by incorporation into the TCA cycle to generate energy for the cell  
(Figure 4). 
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Figure 3; Conversion of D-3-HB to acetoacetate by BdhA enzyme 
 
Figure 4; Catabolic pathway for conversion of D-3-HB to acetyl-CoA in the P. aeruginosa cell. 
The catalytic properties and structure of the enzyme responsible for the conversion of 3-
HB to acetoacetate has been well characterized [7]. The name of this enzyme is D-3-
hydroxybutyrate dehydrogenase (BdhA) and it is coded by the bdhA (PA2003) gene in the P. 
aeruginosa genome. Directly upstream to the transcription start site the bdhA gene exists the 
PA2004 and PA2005 genes (Figure 5). Unlike the bdhA gene, the protein products of the 
PA2004 and PA2005 genes have not been characterized. The predicted structure of the proteins 
coded by the PA2004 and PA2005 genes suggest they function as a transmembrane symporter 
and transcriptional regulator, respectively. 
 
Figure	  5;	  Location	  of	  the	  bdhA,	  PA2004,	  and	  PA2005	  genes	  in	  the	  P.	  aeruginosa	  genome.	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The lack of ability to produce PHB, but the presence of a cytosolic enzyme for the 
catabolism of D-3-hydroxybutyrate, suggests that Pseudomonas aeruginosa must have a method 
for the uptake of extracellular D-3-HB into the cell. This statement is further supported by the 
presence of the extracellular depolymerase (PhaZ) capable of degrading PHB into individual 
units of D-3-HB [8]. The PA2004 gene is hypothesized to be responsible for the uptake of D-3-
HB into the cell based its location on the P. aeruginosa genome and the hypothetical structure of 
the gene’s protein product. PA2004 is located upstream of the bdhA transcription start site and is 
separated by a 25 base pair intergenic sequence. The sequence of the PA2004 gene codes for ten 
predicted transmembrane domains and has structural similarity to various H+/ gluconate 
symporters and citrate transporters located within the P. aeruginosa genome. Furthermore, the 
transcriptional direction of the open reading frame of the PA2004 is in the same direction as the 
ORF for the bdhA gene. Based on the various characteristics discussed, there exists a strong 
likelihood that both bdhA and PA2004 are transcribed as a single operon. Bacterial operons that 
code for multiple proteins involved in the metabolism of a single substrate have been 
characterized before, such as the well-known LacZ operon. The existence of such systems allows 
for regulation by transcriptional activators or repressors and also ensures that all genes for a 
specific metabolic function are being transcribed only when metabolically necessary. 
Regulation of transcription of the hypothesized bdhA-PA2004 gene operon appears to be 
accomplished by the alternative sigma factor, RpoN. Evidence for this claim is based on the 
presence of a conserved recognition sequence for RpoN upstream to the transcription start site of 
the PA2004 gene [11]. In order for this sigma factor to properly orient RNA polymerase and 
initiate transcription, enhancer binding proteins are required to assist in opening of double 
stranded DNA by the RpoN-RNA polymerase complex [9]. Enhancer binding proteins involved 
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in RpoN mediated transcription require an ATP-dependent reaction to initiate the opening of the 
double stranded DNA complex [1]. An AAA+ ATPase domain for this ATP catalyzed reaction 
as well as DNA binding domains for specific regions of the genome in order to properly orient 
the RNA polymerase holoenzyme for transcription are the most common features of enhancer 
binding proteins associated with RpoN [1].  
The predicted structure of the PA2005 gene product contains both DNA binding domains 
as well as an AAA+ ATPase domain. The presence of these regions on the PA2005 gene 
strongly suggests the role of the PA2005 protein is that of a transcriptional regulator enhancer 
binding protein involved in RpoN mediated transcription. Furthermore, it is believed that the 
PA2005 protein specifically binds to a region of DNA located between the PA2004 and PA005 
genes in the P. aeruginosa genome (Figure 6) and is vital for the expression of genes required for 
the metabolism of D-3-hydroxybutyrate.  
 
	  
Figure	  6;	  Reading	  frames	  of	  the	  bdhA,	  PA2004,	  and	  PA2005	  genes	  as	  well	  as	  the	  predicted	  
binding	  region	  of	  RpoN	  on	  the	  P.	  aeruginosa	  genome.	  
	  
A	  schematic	  representing	  the	  hypothesized	  mechanism	  in	  which	  the	  transcription	  of	  
D-­‐3-­‐hydroxybutyrate	  catabolic	  genes	  are	  activated	  can	  be	  seen	  in	  Figure	  7.	  During	  Phase	  I,	  
extracellular	  PHB	  is	  first	  broken	  down	  into	  its	  monomeric	  form	  (D-­‐3-­‐HB)	  by	  the	  PhaZ	  
depolymerase.	  Uptake	  of	  D-­‐3-­‐HB	  then	  occurs	  at	  low	  levels	  by	  the	  PA2004	  gene,	  which	  may	  
be	  transcribed	  at	  basal	  levels	  in	  the	  cell	  at	  all	  times,	  or	  may	  be	  accomplished	  by	  the	  PA2002	  
gene,	  which	  is	  believed	  to	  code	  for	  a	  non-­‐specific	  short	  chain	  fatty	  acid	  transporter.	  Once	  
	   10	  
inside	  the	  cell,	  D-­‐3-­‐HB	  likely	  binds	  to	  the	  PA2005	  enhancer	  binding	  protein	  and	  activates	  it	  
by	  causing	  a	  conformational	  change	  in	  EBP	  structure.	  During	  Phase	  II,	  the	  now	  active	  
PA2005	  EBPs	  bind	  to	  a	  region	  of	  the	  DNA	  upstream	  of	  the	  RpoN	  site	  located	  between	  the	  
PA2004	  and	  PA2005	  genes.	  EBP	  binding	  and	  subsequent	  ATP	  activation	  causes	  a	  
conformational	  change	  in	  sigma	  54	  (RpoN)	  that	  ultimately	  allows	  for	  the	  melting	  of	  the	  
DNA	  double	  helix	  which	  will	  then	  initiate	  transcription	  by	  RNA	  polymerase.	  Transcription,	  
followed	  by	  translation,	  of	  the	  bdhA-­‐PA2004	  gene	  operon	  will	  then	  lead	  to	  greatly	  
increased	  levels	  of	  the	  PA2004	  transporter	  and	  BdhA	  dehydrogenase	  proteins	  inside	  the	  
cell	  (cell	  membrane).	  Increased	  amounts	  of	  the	  PA2004	  transporter	  will	  influence	  the	  rate	  
of	  uptake	  of	  D-­‐3-­‐HB	  into	  the	  cell	  and	  the	  conversion	  of	  D-­‐3-­‐HB	  to	  acetoacetate	  by	  the	  now	  
present	  BdhA	  protein	  will	  allow	  for	  the	  P.	  aeruginosa	  cell	  to	  use	  this	  substrate	  (D-­‐3-­‐HB)	  as	  





Figure	  7.	  Schematic	  of	  EBP	  (PA2005)	  activation	  caused	  by	  the	  uptake	  of	  D-­‐3-­‐HB	  [Phase	  I]	  
followed	  by	  transcription	  of	  the	  bdhA-­‐PA2004	  gene	  operon	  mediated	  by	  sigma	  factor	  54	  
and	  the	  activated	  EBPs	  [Phase	  II].	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Methods	  
Obtaining	  D-­‐3-­‐HB	  Catabolism	  Mutants	  
	   Pseudomonas	  aeruginosa	  PAO1	  mutant	  phenotype	  strains	  lacking	  function	  of	  the	  
PA2003	  (bdhA),	  PA2004,	  and	  PA2005	  genes	  were	  obtained	  from	  the	  University	  of	  
Washington’s	  PA	  2-­‐Allele	  Library.	  The	  three	  mutant	  strains	  obtained	  each	  had	  single	  
transposon	  mutations	  in	  either	  the	  PA2003,	  PA2004,	  or	  PA2005	  genes.	  Verification	  of	  the	  
described	  mutations	  was	  performed	  using	  forward	  and	  reverse	  primers	  for	  each	  gene	  and	  
amplification	  using	  PCR.	  The	  Pseudomonas	  aeruginosa	  wild-­‐type	  strain,	  PAO1,	  was	  used	  as	  
a	  control	  for	  this	  experiment.	  	  
Initial	  Growth	  Assays	  
Once	  the	  D-­‐3-­‐HB	  transposon	  mutants	  were	  obtained,	  a	  series	  of	  growth	  assays	  were	  
performed	  to	  verify	  the	  necessity	  of	  each	  gene	  for	  survival	  on	  a	  variety	  of	  carbon	  sources.	  
The	  non-­‐transformed	  mutant	  strains	  for	  each	  gene	  were	  grown	  in	  enriched	  media,	  as	  well	  
as	  minimal	  media	  containing	  DL-­‐3-­‐hydroxybutyrate,	  succinate,	  or	  acetate.	  	  
Lennox	  Broth	  
	   Wild-­‐type	  PAO1	  as	  well	  as	  the	  PA2003,	  PA2004,	  and	  PA2005	  transposon	  mutants	  
were	  plated	  onto	  LB	  and	  incubated	  for	  an	  18-­‐hour	  period	  at	  37oC.	  Individual	  colonies	  were	  
chosen	  from	  each	  plate	  and	  used	  to	  inoculate	  separate	  culture	  tubes	  containing	  2-­‐mL	  of	  LB.	  
Incubation	  took	  place	  for	  a	  24-­‐hour	  period	  at	  37oC	  with	  200	  RPM	  shaking.	  After	  24-­‐hour	  
incubation	  period,	  0.5%	  of	  each	  cell	  culture	  was	  used	  to	  inoculate	  500-­‐mL	  baffled	  shake	  
flasks	  containing	  50-­‐mL	  of	  LB	  rich	  media.	  An	  initial	  optical	  density	  reading	  was	  taken	  at	  
600	  nm	  using	  an	  LB	  blank.	  Flasks	  were	  then	  incubated	  for	  a	  7-­‐hour	  period	  at	  37oC	  with	  200	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RPM	  shaking.	  Data	  points	  were	  collected	  every	  hour	  in	  the	  same	  manner	  as	  the	  initial	  data	  
point	  using	  appropriate	  dilutions	  when	  necessary.	  
DL-­‐3-­‐HB,	  Succinate,	  and	  Acetate	  
	   Wild-­‐type	  PAO1	  as	  well	  as	  the	  PA2003,	  PA2004,	  and	  PA2005	  transposon	  mutants	  
were	  plated	  onto	  LB	  and	  incubated	  for	  an	  18-­‐hour	  period	  at	  37oC.	  Individual	  colonies	  were	  
chosen	  from	  each	  plate	  and	  used	  to	  inoculate	  separate	  culture	  tubes	  containing	  2-­‐mL	  of	  LB.	  
Incubation	  took	  place	  for	  a	  24-­‐hour	  period	  at	  37oC	  with	  200	  RPM	  shaking.	  After	  24-­‐hour	  
incubation	  period,	  1.5-­‐mL	  of	  each	  cell	  culture	  was	  pelleted	  for	  3	  minutes	  (13.2	  X	  1000	  
RPM).	  Cell	  pellets	  were	  resuspended	  with	  1-­‐mL	  of	  M63	  minimal	  media	  and	  used	  to	  
inoculate	  separate	  500-­‐mL	  baffled	  shake	  flasks	  containing	  50-­‐mL	  30	  mM	  carbon	  source	  
(DL-­‐3-­‐HB,	  succinate,	  or	  acetate),	  M63	  minimal	  media/	  5	  uM	  FeSO4/	  2	  mM	  MgSO4/	  pH	  7.1.	  
An	  initial	  optical	  density	  reading	  was	  taken	  at	  600	  nm	  using	  a	  water	  blank.	  Flasks	  were	  
then	  incubated	  for	  a	  7-­‐hour	  period	  (succinate/	  acetate)	  or	  a	  14-­‐hour	  period	  (DL-­‐3-­‐HB)	  at	  
37oC	  with	  200	  RPM	  shaking.	  Data	  points	  were	  collected	  every	  hour	  (succinate/	  acetate)	  or	  
every	  two	  hours	  (DL-­‐3-­‐HB)	  in	  the	  same	  manner	  as	  the	  initial	  data	  point	  using	  appropriate	  
dilutions	  when	  necessary.	  
Cloning	  and	  Construction	  of	  D-­‐3-­‐HB	  Catabolism	  Gene	  Vectors	  
	  
The	  forward	  and	  reverse	  primers	  for	  the	  PA2003,	  PA2004,	  and	  PA2005	  genes	  used	  
for	  the	  PCR	  experiment	  were	  also	  used	  to	  create	  expression	  vectors.	  A	  total	  of	  four	  broad-­‐
host	  range	  vectors	  were	  constructed	  using	  the	  pBBR1MCS5	  expression	  parent	  vector.	  The	  
first	  vector	  constructed	  contained	  the	  PA2003	  gene	  (pBRL496).	  The	  pBRL498	  vector	  
contained	  both	  the	  PA2003	  and	  PA2004	  genes	  in	  a	  single	  insert,	  just	  as	  the	  genes	  appear	  in	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the	  P.	  aeruginosa	  genome	  as	  a	  single	  operon.	  The	  pBRL501	  gene	  contained	  the	  PA2004	  
gene	  in	  the	  pBBR1MCS5	  vector.	  Lastly,	  the	  pJRH010	  vector	  was	  constructed	  by	  inserting	  
the	  PA2005	  gene,	  along	  with	  a	  6X	  His-­‐Tag	  on	  the	  5’	  end	  of	  the	  gene,	  into	  the	  pBBR1MCS5	  
host	  vector.	  	  The	  three	  mutant	  strains	  of	  P.	  aeruginosa	  were	  transformed	  with	  each	  of	  the	  
four	  vectors	  using	  electroporation	  techniques.	  A	  total	  of	  12	  transformed	  strains	  were	  
created;	  each	  of	  the	  three	  mutant	  strains	  with	  each	  of	  the	  four	  described	  expression	  
vectors.	  In	  addition	  to	  the	  P.	  aeruginosa	  strains,	  E.	  coli	  MG1655	  was	  also	  transformed	  by	  
electroporation	  using	  the	  four	  described	  vectors	  as	  well	  as	  the	  empty	  parent	  vector	  for	  a	  
total	  of	  five	  transformed	  E.	  coli	  MG1655	  strains.	  
DL-­‐3-­‐HB	  Recovery	  Assays	  using	  Pseudomonas	  aeruginosa	  
	  
A	  series	  of	  recovery	  assays	  were	  performed	  using	  the	  D-­‐3-­‐HB	  mutant	  phenotypes	  
transformed	  with	  the	  previously	  described	  vectors	  (12	  total	  strain-­‐vector	  combinations).	  	  
All	  complementation	  assays	  were	  performed	  in	  the	  same	  manner	  as	  the	  previous	  growth	  
assays	  using	  DL-­‐3-­‐HB	  as	  the	  sole	  carbon	  source	  in	  M63	  minimal	  media	  and	  PAO1	  as	  the	  
control.	  Methods	  for	  these	  assays	  were	  the	  same	  as	  the	  initial	  assays	  using	  DL-­‐3-­‐HB	  except	  
the	  antibiotic	  gentamycin	  was	  present	  in	  plates	  and	  seed	  cultures	  at	  a	  concentration	  of	  45-­‐
ng/	  uL	  for	  all	  strains	  that	  contained	  a	  vector,	  but	  not	  for	  PAO1	  control	  plates	  and	  cultures.	  
Incubation	  conditions	  and	  assay	  techniques	  were	  the	  same	  as	  initial	  growth	  assays	  in	  DL-­‐3-­‐
HB.	  
DL-­‐3-­‐HB	  Growth	  Assays	  using	  E.	  coli	  MG1655	  
	  
A	  series	  of	  growth	  assays	  were	  performed	  using	  the	  E.	  coli	  MG1655	  strains	  
transformed	  with	  the	  previously	  described	  vectors	  (5	  total	  strain-­‐vector	  combinations).	  	  All	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complementation	  assays	  were	  performed	  in	  the	  same	  manner	  as	  the	  previous	  growth	  
assays	  using	  DL-­‐3-­‐HB	  as	  the	  sole	  carbon	  source	  in	  M63	  minimal	  media.	  The	  E.	  coli	  MG1655	  
strain	  transformed	  with	  the	  empty	  parent	  vector	  served	  as	  the	  control	  for	  these	  
experiments.	  Methods	  for	  these	  assays	  were	  the	  same	  as	  the	  initial	  assays	  using	  DL-­‐3-­‐HB	  
except	  the	  antibiotic	  gentamycin	  was	  present	  in	  plates	  and	  seed	  cultures	  at	  a	  concentration	  
of	  15	  ng/	  uL	  for	  all	  strains.	  Incubation	  conditions	  and	  assay	  techniques	  were	  the	  same	  as	  
initial	  growth	  assays	  in	  DL-­‐3-­‐HB	  except	  growth	  was	  assayed	  starting	  at	  hour-­‐12	  and	  
continued	  every	  two	  hours	  for	  a	  total	  growth	  period	  of	  28	  hours.	  
Results	  
Obtaining	  D-­‐3-­‐HB	  Catabolism	  Mutants	  
	  
The	  results	  of	  the	  PCR	  experiment	  (image	  not	  shown)	  verified	  that	  the	  three	  mutant	  
strains	  (PA2003::Tn,	  PA2004::Tn,	  and	  PA2005::Tn)	  obtained	  from	  the	  University	  of	  
Washington’s	  PA	  2-­‐Allele	  Library	  each	  lacked	  the	  proper	  size,	  and	  therefore	  functionality,	  
of	  one	  of	  the	  three	  genes	  listed	  while	  maintaining	  the	  integrity	  of	  the	  other	  two	  genes,	  as	  
compared	  to	  PAO1.	  These	  results	  ensured	  that	  all	  growth	  and	  recovery	  assays	  performed	  
used	  true	  phenotype	  mutants.	  
Initial	  Growth	  Assays	  
Lennox	  Broth	  
	  
	   The	  results	  of	  the	  initial	  growth	  assays	  using	  the	  three	  transposon	  mutants	  and	  
PAO1	  wild-­‐type	  grown	  in	  LB	  indicated	  that	  all	  strains	  expressed	  similar	  growth	  rates	  
(Figure	  8).	  These	  results	  support	  the	  idea	  that	  the	  genes	  being	  studied	  (PA2003,	  PA2004,	  
and	  PA2005)	  do	  not	  directly	  influence	  normal	  metabolism	  and	  growth	  in	  rich	  media.	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Figure	  8.	  PAO1	  D-­‐3-­‐HB	  metabolism	  mutant	  phenotypes	  exhibit	  normal	  growth	  rates	  in	  LB.	  
	  
DL-­‐3-­‐HB,	  Succinate,	  and	  Acetate	   	  
	   Based	  on	  the	  results	  of	  these	  experiments	  (Figure	  9),	  it	  can	  be	  seen	  that	  the	  growth	  
rates	  of	  the	  transposon	  mutants	  compared	  to	  PAO1	  wild-­‐type	  are	  the	  same	  when	  acetate	  
and	  succinate	  are	  the	  sole	  carbon	  source,	  but	  growth	  of	  mutant	  strains	  in	  DL-­‐3-­‐HB	  is	  
greatly	  reduced	  compared	  to	  that	  of	  the	  wild-­‐type	  strain.	  These	  results	  support	  the	  idea	  
that	  the	  genes	  of	  interest	  (PA2003,	  PA2004,	  and	  PA2005)	  do	  not	  directly	  influence	  normal	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C)	  
	  
Figure	  9.	  The	  growth	  rates	  of	  PAO1	  D-­‐3-­‐HB	  metabolism	  mutant	  phenotypes	  compared	  to	  
PAO1	  wild-­‐type	  is	  the	  same	  when	  grown	  in	  M63	  minimal	  media	  and	  30	  mM	  acetate	  as	  the	  
sole	  carbon	  source	  (A),	  is	  the	  same	  when	  grown	  in	  M63	  minimal	  media	  and	  30	  mM	  
succinate	  as	  the	  sole	  carbon	  source	  (B),	  and	  is	  greatly	  reduced	  when	  grown	  in	  M63	  minimal	  
media	  and	  30	  mM	  DL-­‐3-­‐HB	  as	  the	  sole	  carbon	  source	  (C).	  
	  
DL-­‐3-­‐HB	  Recovery	  Assays	  using	  Pseudomonas	  aeruginosa	  
PA2003::Tn	  (bdhA	  Mutant)	  
	  
	   Recovery	  of	  the	  PA2003::Tn	  (bdhA)	  mutant	  was	  accomplished	  when	  complemented	  
with	  the	  bdhA	  and	  bdhA-­‐PA2004	  vectors	  (Figure	  10).	  These	  results	  were	  expected	  due	  to	  
the	  straightforward	  nature	  of	  the	  complementations	  performed	  and	  the	  fact	  that	  BdhA	  
structure	  and	  function	  has	  been	  previously	  characterized.	  Adversely	  to	  these	  results,	  
growth	  of	  the	  PA2003::Tn	  mutant	  was	  decreased	  even	  further	  compared	  to	  PAO1	  wild-­‐type	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disruption	  of	  metabolic	  function	  caused	  by	  these	  vectors	  beyond	  lack	  of	  the	  bdhA	  gene	  
alone.	  
	  
Figure	  10.	  The	  bdhA	  and	  bdhA-­‐PA2004	  vectors	  restored	  growth	  in	  the	  PA2003(bdhA)::Tn	  
mutant.	  
	  
PA2004::Tn	  (D-­‐3-­‐HB	  Transporter	  Mutant)	  
Recovery	  of	  the	  PA2004::Tn	  (D-­‐3-­‐HB	  Transporter)	  mutant	  was	  accomplished	  when	  
complemented	  with	  the	  bdhA-­‐PA2004	  vector	  (Figure	  11).	  Partial	  recovery	  was	  
accomplished	  with	  the	  bdhA	  vector	  alone.	  This	  partial	  recovery	  by	  the	  bdhA	  vector	  
supports	  the	  idea	  that	  P.	  aeruginosa	  has	  an	  alternate	  method	  for	  uptake	  of	  D-­‐3-­‐HB.	  
Adversely	  to	  these	  results,	  growth	  of	  the	  PA2003::Tn	  mutant	  was	  decreased	  even	  further	  
compared	  to	  PAO1	  wild-­‐type	  when	  complemented	  with	  the	  PA2004	  and	  PA2005	  vectors,	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Figure	  11.	  The	  bdhA-­‐PA2004	  vector	  restored	  growth	  and	  the	  bdhA	  vector	  partially	  restored	  
growth	  in	  the	  PA2004::Tn	  mutant.	  
	  
PA2005::Tn	  (EBP	  Mutant)	  
	  
Partial	  recovery	  of	  the	  PA2005::Tn	  (D-­‐3-­‐HB	  Transporter)	  mutant	  was	  accomplished	  
when	  complemented	  with	  the	  bdhA,	  bdhA-­‐PA2004,	  and	  PA2005	  (EBP)	  vectors	  (Figure	  12).	  
Recovery	  of	  growth	  granted	  by	  the	  PA2005	  vector	  was	  expected	  in	  the	  PA2005::Tn	  mutant	  
because	  it	  was	  a	  true	  complementation.	  Partial	  recovery	  by	  the	  bdhA	  vector	  supports	  the	  
idea	  that	  P.	  aeruginosa	  has	  an	  alternate	  method	  for	  uptake	  of	  D-­‐3-­‐HB,	  as	  was	  similar	  for	  the	  
PA2004:Tn	  mutant	  complemented	  with	  the	  bdhA	  vector.	  Adversely	  to	  these	  results,	  growth	  
of	  the	  PA2005::Tn	  mutant	  was	  decreased	  even	  further	  compared	  to	  PAO1	  wild-­‐type	  when	  
complemented	  with	  the	  PA2004,	  which	  indicates	  further	  disruption	  of	  metabolic	  function	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Figure	  12.	  The	  bdhA,	  bdhA-­‐PA2004,	  and	  PA2005	  vectors	  partially	  restored	  growth	  in	  the	  
PA2005::Tn	  mutant.	  
	  
DL-­‐3-­‐HB	  Growth	  Assays	  using	  E.	  coli	  MG1655	  
	  
	   Based	  on	  the	  results	  of	  the	  growth	  assays	  performed	  (Figure	  13)	  it	  is	  apparent	  that	  
both	  the	  bdhA	  	  and	  the	  bdhA-­‐PA2004	  vectors	  provided	  a	  novel	  ability	  of	  DL-­‐3-­‐HB	  
catabolism	  in	  E.	  coli	  MG1655.	  Growth	  of	  E.	  coli	  MG1655	  with	  the	  bdhA	  vector	  alone	  
supports	  the	  idea	  that	  E.	  coli	  has	  a	  mechanism	  for	  uptake	  of	  short-­‐chain	  fatty	  acids,	  











Growth	  of	  PA2005::Tn	  Pseudomonas	  aeruginosa	  PAO1	  on	  







	   21	  
	  
Figure	  13.	  E.	  coli	  MG1655	  complemented	  with	  the	  bdhA	  and	  bdhA-­‐PA2004	  vectors	  provided	  
novel	  D-­‐3-­‐hydroxybutyrate	  catabolism.	  	  	  
Discussion	  
The	  	  bdhA	  gene	  is	  required	  for	  D-­‐3-­‐HB	  Metabolism	  
	  
	   The	  role	  of	  the	  PA2003,	  PA2004,	  and	  PA2005	  genes	  in	  regards	  to	  the	  metabolism	  of	  
D-­‐3-­‐hydroxybutyrate	  has	  been	  elucidated	  by	  the	  results	  of	  this	  study.	  The	  PA2003	  gene,	  
which	  codes	  for	  a	  dehydrogenase	  enzyme	  specific	  for	  the	  conversion	  of	  D-­‐3-­‐HB	  to	  
acetoacetate,	  has	  already	  been	  characterized.	  However,	  this	  study	  has	  proven	  that	  the	  
BdhA	  protein	  is	  absolutely	  necessary	  for	  catabolism	  of	  D-­‐3-­‐HB	  as	  well	  as	  the	  role	  of	  the	  
bdhA	  gene	  within	  the	  bdhA-­‐PA2004	  gene	  operon.	  Initial	  growth	  assays	  in	  which	  the	  
PA2003::Tn	  mutant	  was	  unable	  to	  survive	  on	  DL-­‐3-­‐HB	  as	  the	  sole	  carbon	  source	  proved	  
that	  P.	  aeruginosa	  does	  not	  have	  any	  other	  enzymes	  capable	  of	  catabolizing	  D-­‐3-­‐HB	  into	  a	  
usable	  form	  of	  carbon.	  Complementation	  assays	  using	  a	  vector	  containing	  the	  bdhA	  gene	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restored	  growth	  to	  a	  normal	  rate,	  in	  comparison	  to	  PAO1	  wild-­‐type,	  further	  supporting	  role	  
of	  BdhA	  as	  the	  sole	  D-­‐3-­‐HB	  catabolic	  enzyme.	  	  
The	  bdhA	  and	  PA2004	  genes	  are	  coded	  on	  a	  single	  operon	  
	  
	   The	  transcription	  of	  the	  bdhA-­‐PA2004	  gene	  as	  a	  single	  gene	  operon	  was	  evidenced	  
by	  the	  complementation	  assays	  of	  the	  PA2004::Tn	  mutant.	  During	  this	  set	  of	  recovery	  
assays,	  the	  PA2004::Tn	  mutant	  did	  not	  recover	  growth	  when	  complemented	  with	  a	  vector	  
containing	  the	  PA2004	  gene.	  This	  somewhat	  counter-­‐intuitive	  result	  is	  best	  explained	  as	  
being	  caused	  by	  a	  polar	  effect	  on	  the	  bdhA	  gene	  due	  to	  the	  transposon	  insertion	  into	  the	  
PA2004	  gene.	  The	  reading	  frame	  of	  the	  bdhA-­‐PA2004	  gene	  operon	  is	  oriented	  in	  such	  a	  
way	  that	  the	  PA2004	  gene	  is	  transcribed	  first,	  followed	  by	  transcription	  of	  the	  bdhA	  gene.	  
The	  PA2004::Tn	  mutant	  has	  a	  transposon	  insertion	  in	  the	  PA2004	  gene	  that	  causes	  a	  
disruption	  of	  transcription	  of	  the	  entire	  operon	  and	  effectively	  causes	  the	  PA2004::Tn	  
mutant	  to	  not	  only	  lack	  function	  of	  the	  PA2004	  gene,	  but	  also	  the	  bdhA	  gene,	  even	  though	  
the	  integrity	  of	  the	  bdhA	  gene	  sequence	  is	  intact	  in	  the	  PA2004::Tn	  mutant.	  This	  overall	  
phenomenon	  can	  best	  be	  described	  as	  a	  polar	  effect	  of	  the	  PA2004	  transposon	  on	  the	  bdhA	  
gene	  and	  greatly	  supports	  the	  claim	  that	  the	  bdhA	  gene	  and	  the	  PA2004	  gene	  are	  coded	  as	  a	  
single	  operon.	  	  
PA2004	  codes	  for	  a	  putative	  D-­‐3-­‐HB	  transporter	  
	  
	   Evidence	  for	  the	  role	  of	  the	  PA2004	  protein	  product	  as	  a	  putative	  D-­‐3-­‐HB	  
transporter	  is	  supported	  by	  the	  its	  predicted	  structure	  based	  on	  the	  amino	  acid	  sequence	  of	  
the	  PA2004	  gene	  as	  well	  as	  the	  performed	  complementation	  assays	  using	  the	  P.	  aeruginosa	  
D-­‐3-­‐HB	  metabolism	  mutants.	  In	  all	  complementation	  assays	  performed	  with	  the	  mutant	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strains,	  the	  PA2004	  vector	  reduced	  growth	  to	  levels	  less	  than	  the	  growth	  rates	  of	  the	  non-­‐
transformed	  mutants.	  In	  those	  specific	  assays	  involving	  the	  PA2004	  vector,	  all	  strains	  
tested	  were	  not	  expressing	  the	  BdhA	  protein.	  The	  PA2003::Tn	  mutant	  had	  a	  transposon	  
mutation	  in	  the	  bdhA	  gene,	  the	  PA2004::Tn	  mutant	  did	  not	  express	  BdhA	  due	  to	  a	  polar	  
effect,	  and	  the	  PA2005::Tn	  mutant	  was	  not	  transcribing	  the	  PA2004	  or	  bdhA	  genes	  at	  all	  
due	  to	  a	  lack	  of	  EBP	  mediated	  activation	  of	  transcription.	  Therefore,	  when	  these	  mutants	  
were	  transformed	  with	  the	  PA2004	  vector,	  the	  cell	  would	  uptake	  large	  amounts	  of	  D-­‐3-­‐HB	  
but	  were	  unable	  to	  catabolize	  it	  further.	  This	  build-­‐up	  of	  D-­‐3-­‐HB	  in	  the	  cell,	  without	  a	  way	  
to	  catabolize	  it	  further,	  caused	  a	  disruption	  of	  ion	  and	  charge	  flux	  within	  the	  cell	  and	  
ultimately	  led	  to	  even	  further	  reduced	  growth	  rates	  than	  non-­‐complemented	  mutants.	  
	   The	  role	  of	  the	  PA2004	  protein	  as	  a	  putative	  D-­‐3-­‐HB	  transporter	  is	  also	  supported	  
by	  the	  fact	  that	  all	  mutant	  strains	  complemented	  with	  the	  bdhA-­‐PA2004	  vector	  expressed	  
growth	  rates	  that	  matched,	  and	  even	  exceeded	  in	  some	  cases,	  the	  normal	  growth	  rates	  of	  
the	  P.	  aeruginosa	  wild-­‐type	  strain	  grown	  in	  D-­‐3-­‐HB	  as	  the	  sole	  carbon	  source.	  An	  additional	  
conclusion	  that	  can	  be	  drawn	  from	  the	  mutant	  complementation	  assays,	  in	  regards	  to	  D-­‐3-­‐
HB	  transport,	  are	  the	  results	  showing	  that	  the	  PA2004	  and	  PA2005	  mutant	  strains	  were	  
able	  to	  partially	  recover	  growth	  when	  complemented	  with	  the	  bdhA	  vector	  alone.	  Without	  
the	  presence	  of	  the	  PA2004	  transporter,	  the	  fact	  that	  any	  growth	  recovered	  at	  all	  indicates	  
that	  P.	  aeruginosa	  may	  have	  alternate	  mechanisms	  for	  uptake	  of	  D-­‐3-­‐HB,	  such	  as	  a	  non-­‐
specific	  short	  chain	  fatty	  acid	  transporter	  that	  may	  be	  coded	  for	  by	  the	  PA2002	  gene.	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PA2005	  is	  an	  enhancer	  binding	  protein	  that	  regulates	  the	  transcription	  of	  the	  bdhA-­‐PA2004	  
operon	  
	  
	   It	  appears	  that	  the	  PA2005	  gene	  contains	  a	  sequence	  for	  a	  putative	  enhancer	  
binding	  protein	  necessary	  for	  transcription	  of	  the	  bdhA-­‐PA2004	  operon.	  This	  claim	  is	  
supported	  by	  the	  results	  of	  the	  complementation	  assays	  involving	  the	  PA2005::Tn	  mutant	  
strain.	  During	  this	  portion	  of	  the	  study,	  a	  partial	  to	  full	  recovery	  of	  growth	  on	  D-­‐3-­‐HB	  as	  the	  
sole	  carbon	  source	  was	  attained	  when	  the	  PA2005::Tn	  mutant	  was	  complemented	  with	  the	  
bdhA,	  bdhA-­‐PA2004,	  and	  the	  PA2005	  vectors.	  The	  fact	  that	  a	  vector	  containing	  genes	  other	  
than	  the	  PA2005	  sequence	  could	  circumvent	  the	  lack	  of	  function	  of	  the	  PA2005	  gene	  
clearly	  shows	  that	  protein	  coded	  by	  PA2005	  plays	  a	  regulatory	  role	  in	  the	  expression	  of	  D-­‐
3-­‐HB	  metabolic	  genes.	  	  
	   The	  function	  of	  the	  PA2005	  gene	  product	  as	  a	  putative	  enhancer	  binding	  protein	  is	  
further	  proven	  by	  the	  fact	  that	  the	  PA2003::Tn,	  and	  PA2004::Tn	  mutants	  had	  reduced	  
growth	  rates	  when	  transformed	  with	  the	  PA2005	  vector	  and	  grown	  in	  D-­‐3-­‐HB	  as	  the	  sole	  
carbon	  source,	  as	  compared	  with	  their	  non-­‐complemented	  counterparts.	  Non-­‐specific	  
binding	  by	  the	  PA2005	  protein	  throughout	  the	  P.	  aeruginosa	  genome	  at	  high	  levels	  due	  to	  
over-­‐expression	  of	  the	  PA2005	  vector	  likely	  disrupted	  normal	  metabolic	  function	  and	  was	  
the	  cause	  of	  the	  further	  reduction	  in	  growth	  rates	  of	  the	  PA2003:Tn	  and	  PA2004::Tn	  
mutants.	  Lastly,	  complementation	  of	  the	  PA2005::Tn	  mutant	  with	  the	  PA2005	  vector	  
restored	  normal	  function	  and	  ensures	  the	  validity	  of	  the	  previous	  claims.	  
Novel	  D-­‐3-­‐HB	  catabolism	  was	  established	  in	  E.	  coli	  MG1655	  
	  
The	  last	  set	  of	  growth	  assays	  performed	  involving	  E.	  coli	  MG1655,	  which	  is	  unable	  to	  
utilize	  D-­‐3-­‐Hydroxybutyrate	  as	  a	  carbon	  source,	  proved	  beyond	  a	  doubt	  that	  the	  bdhA	  gene	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is	  the	  sole	  requirement	  for	  conversion	  of	  D-­‐3-­‐HB	  to	  acetoacetate.	  Since	  E.	  coli	  cannot	  
catabolize	  D-­‐3-­‐HB,	  any	  growth	  exhibited	  by	  the	  transformed	  strains	  represents	  a	  novel	  
function	  of	  DL-­‐3-­‐HB	  catabolism	  provided	  by	  the	  vector	  of	  that	  particular	  transformed	  
strain.	  Since	  both	  vectors	  containing	  the	  bdhA	  gene	  allowed	  for	  DL-­‐3-­‐HB	  catabolism,	  and	  
the	  vector	  containing	  only	  the	  PA2004	  gene,	  which	  code	  for	  a	  putative	  D-­‐3-­‐HB	  transporter,	  
did	  not	  exhibit	  growth,	  it	  is	  clear	  that	  E.	  coli	  has	  a	  natural	  mechanism	  for	  DL-­‐3-­‐HB	  uptake.	  
The	  most	  likely	  candidate	  for	  this	  function	  are	  the	  known	  short-­‐chain	  fatty	  acid	  
transporters	  AtoA/AtoD,	  thus	  proving	  E.	  coli	  MG1655	  only	  requires	  the	  catalytic	  action	  of	  
the	  BdhA	  protein	  to	  use	  DL-­‐3-­‐HB	  as	  a	  sole	  carbon	  source.	  
Conclusions	  
	  
There are two broad bases of knowledge that may be affected by the results of this study. 
The first area of relevance pertains to the development of biodegradable plastics. By determining 
the method of regulation of D-3-hydroxybutyrate metabolism in Pseudomonas aeruginosa, 
insight into why this organism is capable of producing various PHAs, but does not produce PHB 
has been provided. As previously stated, PHB is the most commonly occurring PHA in natural 
systems so there appears to be an underlying reason that explains why P. aeruginosa would 
produce short and medium length PHAs, but not PHB, while, at the same time, maintaining the 
ability to degrade PHB. This reason is that the high prevalence of PHB in the natural 
environment produced by other organisms makes it favorable for P. aeruginosa to have a 
mechanism of obtaining energy from PHB, which can then be stored in PHAs of different 
composition that likely cannot be used by other organisms. Simply put, P. aeruginosa cannot 
make PHB because of its ability to degrade PHB. This is favorable for P. aeruginosa because 
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PHB harnessed from other organisms can then be utilized as an energy source or stored as 
another, non-PHB form of PHA. This non-PHB form of PHA is less common than PHB and will 
therefore be lees likely to be catabolized by other competing organisms.  Understanding this 
system may allow future studies to create more efficient PHA producing strains of P. aeruginosa 
and possibly a PHB producing strain by knocking out the genes that degrade PHB and D-3-HB. 
This study will also provide additional insight into the environmental mechanism for the 
degradation of PHB by various bacteria commonly found in soil. As widespread use of 
biodegradable plastics increases, understanding aspects of degradation of these materials could 
lead to even more environmentally friendly designed plastics.  
 The other area of importance that this study has provided insight to is in regards to the 
elucidation of the overall metabolic functions expressed by P. aeruginosa. As an opportunistic 
pathogen, this bacterium is responsible for a variety of illnesses including fatality in 
immunocomprimised patients [6]. In humans, 3-hydroxybutyrate is present as a ketone body in 
the blood during periods of starvation in order to provide energy for the brain. Studies have 
shown that the RpoN sigma factor binding domain is commonly present in the promoter region 
of genes related to a variety of virulence factors [9]. Due the presence of the RpoN promoter 
sequence upstream to the PA2004 start site, it is possible that D-3-hydroxybutyrate metabolism 
could be a factor related to the virulence of this organism. Increases in the metabolic knowledge 
of this organism may be pertinent to the development of new drugs or antibiotics that can be 
used to combat infections in humans. 
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